2010
DOI: 10.1007/s12307-010-0040-9
|View full text |Cite
|
Sign up to set email alerts
|

A Digest on the Role of the Tumor Microenvironment in Gastrointestinal Cancers

Abstract: Experimental studies and analyses of clinical material have convincingly demonstrated that tumor formation and progression occurs through a concerted action of malignant cells and the surrounding microenvironment of the tumor stroma. The tumor microenvironment is comprised of various cell types like fibroblasts, immune cells, vascular cells and bone-marrow-derived cells embedded in the extracellular matrix. This review, focusing on recent findings in the context of gastrointestinal tumors, introduces the diffe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
26
1
1

Year Published

2011
2011
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 34 publications
(29 citation statements)
references
References 135 publications
0
26
1
1
Order By: Relevance
“…22 The stromas of tumors provide a large number of factors that enhance propagation and metastases of tumors and that probably vary with the stromas of different cancers. 23 The results here suggest that STC1 secreted by MSC-like cells in tumor stroma plays a critical role in enhancing the Warburg effect and making tumors resistant to ROS. Therefore blocking antibodies or antagonists to STC1 may be attractive candidates as an adjunct therapy for γ-radiation and other therapies that increase ROS.…”
Section: Discussionmentioning
confidence: 65%
“…22 The stromas of tumors provide a large number of factors that enhance propagation and metastases of tumors and that probably vary with the stromas of different cancers. 23 The results here suggest that STC1 secreted by MSC-like cells in tumor stroma plays a critical role in enhancing the Warburg effect and making tumors resistant to ROS. Therefore blocking antibodies or antagonists to STC1 may be attractive candidates as an adjunct therapy for γ-radiation and other therapies that increase ROS.…”
Section: Discussionmentioning
confidence: 65%
“…However, CAFs comprise a heterogeneous population of cells and are derived from different sources (13). The CAF heterogeneity observed may reflect the variation of CAF involvement in cancer progression.…”
Section: Introductionmentioning
confidence: 99%
“…The conditions in the tumor microenvironment such as hypoxia, increased glycolysis, and other metabolic changes are conducive for metastasis [3]. While solid tumors are rich in quiescent cells, developing tumors contain proliferating cells [4, 5]. Additionally, the tissue architecture of tumors shows a great variation from its normal counterparts in tissue integrity and exhibit differential genetic programming [6-8].…”
Section: Introductionmentioning
confidence: 99%